|June 30, 2014|
|07:43 EDT||PODD, BDX||Insulet enters settlement and license agreement with Becton Dickinson |
Insulet disclosed in a regulatory filing Friday night that on June 23 the company entered into a settlement and license agreement with Becton, Dickinson and Company (BDX) to settle the pending patent infringement lawsuit brought by BD against the company. In exchange for a release of claims, covenant not to sue and license to the patents in suit from BD, the settlement agreement provides that the company will make a one-time payment of $5M to BD and give BD a license to a single company patent relating to an environmental seal for a fluid delivery device. In addition to the settlement payment, it is expected that the company’s legal and other expenses associated with the lawsuit will be up to approximately $2.0M in the second quarter. Following the company’s payment of the settlement payment, the parties will promptly move to dismiss the pending lawsuit by BD, Insulet noted.
News For PODD;BDX From The Last 14 Days
|January 28, 2015|
|09:26 EDT||PODD||Leerink medical devices analyst holds an analyst/industry conference call|
Medical Devices Analyst Antalffy assesses the rapidly-evolving diabetes landscape and the potential growth trajectory for Insulet's OmniPod and DexCom's CGM on an Analyst/Industry conference call to be held on January 29 at 2 pm.
|January 26, 2015|
|10:00 EDT||PODD||On The Fly: Analyst Downgrade Summary|
Subscribe for More Information
|06:53 EDT||PODD||Insulet downgraded to Market Perform from Outperform at William Blair|
William Blair downgraded Insulet to Market Perform citing weaker domestic insulin pump market trends.
|January 21, 2015|
|16:48 EDT||BDX||CareFusion stockholders approve proposed merger with Becton, Dickinson |
Becton, Dickinson and Company (BDX) and CareFusion (CFN) announced the results of the CareFusion special meeting of stockholders, held on January 21, for CareFusion stockholders to consider and vote upon the proposed merger of CareFusion and BD. CareFusion stockholders approved the definitive merger agreement and the merger transaction, with approximately 76% of shares outstanding cast in favor of the proposal. As previously announced on October 5, 2014, BD and CareFusion entered into a definitive agreement pursuant to which BD would acquire CareFusion in a stock and cash transaction. CareFusion stockholder approval was a condition to the merger. The proposed acquisition remains subject to certain other conditions and approvals, including approval of the proposed acquisition by the European Commission under the European Union Merger Regulation.
|10:01 EDT||BDX||On the Fly: Analyst Upgrade Summary|
Today's noteworthy upgrades include: Ashford Hospitality (AHT) upgraded to Outperform from Neutral at Credit Suisse... BAE Systems (BAESY) upgraded to Buy from Neutral at Goldman... Bazaarvoice (BV) upgraded to Outperform from Market Perform at Cowen... Becton Dickinson (BDX) upgraded to Outperform at Cowen... CVS Health (CVS) upgraded to Buy from Neutral at Goldman... Camden Property (CPT) upgraded to Outperform from Neutral at Credit Suisse... ConocoPhillips (COP) upgraded to Buy from Neutral at BofA/Merrill... Cornerstone OnDemand (CSOD) upgraded to Buy from Neutral at DA Davidson... Cree (CREE) upgraded to Overweight at Stephens... DDR Corp. (DDR) upgraded to Outperform from Neutral at Credit Suisse... EastGroup Properties (EGP) upgraded to Outperform from Neutral at Credit Suisse... Energy Transfer Partners (ETP) upgraded to Outperform from Neutral at Credit Suisse... Esperion (ESPR) upgraded at BofA/Merrill... Exxon Mobil (XOM) upgraded to Outperform from Market Perform at Wells Fargo... FXCM (FXCM) upgraded to Market Perform from Underperform at Keefe Bruyette... Fair Isaac (FICO) upgraded to Overweight from Equal Weight at Barclays... Golar LNG (GLNG) upgraded to Buy from Hold at Nordea... Gran Tierra (GTE) upgraded to Buy at Canaccord... Host Hotels (HST) upgraded to Outperform from Neutral at Credit Suisse... J.M. Smucker (SJM) upgraded to Overweight from Neutral at JPMorgan... Kilroy Realty (KRC) upgraded to Neutral from Underperform at Credit Suisse... Level 3 (LVLT) upgraded to Outperform from Market Perform at Wells Fargo... Lowe's (LOW) upgraded to Overweight from Equal Weight at Morgan Stanley... Michael Kors (KORS) upgraded to Outperform at Cowen... Netflix (NFLX) upgraded at Nomura... Regions Financial (RF) upgraded to Buy from Neutral at Guggenheim... Ruckus Wireless (RKUS) upgraded to Outperform from Market Perform at Northland... Santander Mexico (BSMX) upgraded to Neutral from Underperform at Credit Suisse... Scorpio Tankers (STNG) upgraded to Buy at Canaccord... Sprouts Farmers Markets (SFM) upgraded to Buy from Neutral at BofA/Merrill... Strategic Hotels (BEE) upgraded to Outperform from Neutral at Credit Suisse... The Medicines Co. (MDCO) upgraded to Outperform from Market Perform at Leerink... Whole Foods (WFM) upgraded at Sterne Agee... Wolseley (WOSYY) upgraded to Neutral from Underperform at Exane BNP Paribas.
|09:23 EDT||BDX||Retractable Tech says judge issues final judgment in suit against Becton Dickinson |
Subscribe for More Information
|08:00 EDT||BDX||Becton Dickinson upgraded to Outperform at Cowen|
As previously reported, Cowen upgraded Becton Dickinson (BDX) to Outperform from Market Perform as they believe synergy targets for its Carefusion (CFN) acquisition are too low. Cowen raised its price target to $165 form $130 on Becton Dickinson shares.
|07:31 EDT||PODD||Insulet well positioned to beat expectations, says Leerink|
Leerink believes the worst is now behind Insulet and that the company is positioned for accelerating new patient adds in Q2 and beyond. Leerink thinks lowered base expectations position Insulet to potentially top forecasts in 2015. The firm lowered its price target for shares to $40 and $50 and keeps an Outperform rating on the name.
|06:55 EDT||BDX||Becton Dickinson upgraded to Outperform from Market Perform at Cowen|
Subscribe for More Information